Cargando...
Alemtuzumab as Treatment for Multiple Sclerosis
Alemtuzumab, the first monoclonal antibody to be used as a therapy and the first to be humanized, was introduced into the treatment of multiple sclerosis in 1991 after its successful use in hematology, oncology, and transplantation medicine. One phase 2 and two phase 3 trials of this lymphocyte-depl...
Gardado en:
| Publicado en: | Cold Spring Harb Perspect Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Cold Spring Harbor Laboratory Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6169984/ https://ncbi.nlm.nih.gov/pubmed/29500306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a032029 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|